Welcome to your healthcare community
At Janssen, we believe in partnering with patients and caregivers. By seeing patients as our partners, we can understand how to better meet their needs and improve the patient’s health care journey.
Our Therapy Areas
Blood Cancer
Cancer
Gastroenterology
Pulmonary Arterial Hypertension
.png?width=1920&height=1286&format=webp&quality=50)
Mental Health
Multiple Sclerosis
Psoriatic Disease
At Janssen, we are committed to maintaining the highest level of integrity and compliant conduct. Our purpose with JanssenWithMe is to share fair and balanced information related to the diseases where we can make the biggest difference. The information provided on JanssenWithMe does not promote products or give medical advice.
Mental Health
Mental Health is an essential part of your overall health and wellbeing.
Good mental health means that you are able to recognize your own abilities, adapt to the normal stresses of life, work productively, and contribute to your community. Several social, psychological, and biological factors determine the degree of emotional wellbeing you might experience at any given time.
Major Depressive Disorder (MDD)
Being in a bad mood or feeling sad because something terrible happened is part of a normal, emotionally balanced human life. There are different types of depression and Major Depressive Disorder or MDD is one of them. Major Depressive Disorder (MDD) is a long-lasting, biologically based mood disorder.
Schizophrenia
Schizophrenia is a misunderstood and stigmatized illness. When someone is suffering from a psychotic episode as the result of their Schizophrenia, their normal thought processes are disrupted. This may give people the misperception that the person with Schizophrenia has multiple personalities, which is not the case. The schizophrenic mind is not split but shattered.
Explore our Disease Areas
Psoriasis (Pso)
Inflammatory Bowel Disease
Mantle Cell Lymphoma (MCL)
Multiple Myeloma
Amyloidosis
Our initiatives
.png?width=1080&height=786&format=webp&quality=50)
Go Beyond Expectations
Information and support to help you be more than your psoriasis or psoriatic arthritis.
PHuman
For anyone living with a rare, chronic condition, having access to practical support and resources can be extremely valuable.
MoreToMS
Multiple sclerosis is a disease that affects your nervous system. It can radically alter your life and indirectly affect those who care for you.
My IBD Journey
MyIBDJourney offers guidance on how to plan and manage the range of symptoms you may encounter as an individual living with IBD, allowing you to live your life to the fullest.
Built for the patient journey
Patients have always been at the heart of everything we do. With patients increasingly involved in determining their healthcare options, we remain committed to Patient Engagement and are partnering with patients and caregivers to learn more about their experiences. These precious insights help us ensure we are developing the right medicines, improving clinical trials, and creating educational materials that are accessible and easy to understand.
At Janssen, we believe that patients and their caregivers hold key information on how to improve healthcare processes and systems. We partner directly with patients and caregivers as we develop medicines, improve clinical trials, and create educational materials and support programs. We are committed to working toward patient-inspired innovation, including:
Clinical Trials
Listening to and implementing patient perspectives into clinical trial procedures.
Early Drug Development
Incorporating patient-reported outcomes in medicine labels.
Administrating medicine
Modifying product design for administering medicine based on patient input.
References
[8]
ECDC. Questions and answers on COVID-19: Basic facts. Available from:
[9]
National Institute of Allergy and Infectious Diseases. Coronaviruses. Available from:
[11]
Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment Clin Microbiol Rev. 2017Z;30(1):277–319